Evidence map›Paper›PMID 41933299›Full record

ArticleBMC infectious diseases2026

Scaling trachoma surveillance in endemic areas using machine learning.

Benard W Kulohoma, Colette S A Wesonga

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Benard W KulohomaOrtholog, Nairobi, Kenya. bkulohoma@ortholog.co.ke.
Colette S A WesongaOrtholog, Nairobi, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTrachoma remains a leading infectious cause of blindness in endemic regions despite progress towards global elimination. Accurate and scalable diagnosis remains challenging in areas with limited ophthalmic expertise. We developed and evaluated a reproducible transfer learning model using eyelid image-based data.

methodsWe retrospectively analysed anonymised inner eyelid photographs collected from trachoma prevalence surveys conducted in Ethiopia, Tanzania, Australia, Solomon Islands, Colombia, the Gambia, and Guatemala (n = 572 images). Images were categorized as trachoma (n = 251) or not trachoma (n = 321) based on consensus grades from the Tropical Data certified graders. Data were processed and analysed in R (version 4.4.1) using the keras and tensorflow packages interfaced with Python (version 3.10) through reticulate. A ResNet50 convolutional neural network pretrained on ImageNet was fine-tuned for binary classification. The model was trained for up to 30 epochs with early stopping and adaptive learning-rate reduction. Performance on a held-out validation set (n = 62, 12%) was evaluated using accuracy, sensitivity, specificity, and Cohen's κ.

resultsThe ResNet50 model achieved an overall accuracy of 85.4% (95% CI 76.3-92%) on the validation set. The model achieved a sensitivity of 80.9% for detecting trachoma and a specificity of 90.5% for correctly identifying non-trachoma eyes. Agreement between predictions and grader labels was substantial (κ = 0.71, 95% CI 0.58-0.84).

conclusionOur findings demonstrate the feasibility of using a reproducible R-based deep learning pipeline for automated trachoma classification in large-scale surveys. These findings demonstrate the feasibility of automated trachoma classification using a transfer-learning framework. Larger datasets will be required before operational deployment in surveillance programmes. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Endemic DiseasesMachine LearningTrachomaAustraliaConvolutional Neural NetworksEthiopiaHumansPrevalenceRetrospective StudiesSensitivity and SpecificityTanzaniaBlindnessMachine learningR-workflowSurveillanceTrachoma

Identifiers

PMID41933299
PMCPMC13536620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.